61 related articles for article (PubMed ID: 12908341)
1. [Polycystic ovarian disease: clinical and biochemical expression].
González Centeno A; Hernández Marín I; Mendoza R; Tovar Rodríguez JM; Ayala AR
Ginecol Obstet Mex; 2003 May; 71():253-8. PubMed ID: 12908341
[TBL] [Abstract][Full Text] [Related]
2. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between menstruation disorders and insulin resistance].
González Centeno A; Nahum Hernández P; Mendoza R; Ayala AR
Ginecol Obstet Mex; 2003 Jun; 71():312-7. PubMed ID: 14515662
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
6. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
[TBL] [Abstract][Full Text] [Related]
7. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
[TBL] [Abstract][Full Text] [Related]
9. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome.
Shelley DR; Dunaif A
Compr Ther; 1990 Nov; 16(11):26-34. PubMed ID: 2269012
[TBL] [Abstract][Full Text] [Related]
11. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.
Mor E; Zograbyan A; Saadat P; Bayrak A; Tourgeman DE; Zhang C; Stanczyk FZ; Paulson RJ
Am J Obstet Gynecol; 2004 Jun; 190(6):1654-60. PubMed ID: 15284763
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
13. Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome.
Pandolfi C; Zugaro A; Lattanzio F; Necozione S; Barbonetti A; Colangeli MS; Francavilla S; Francavilla F
Metabolism; 2008 Jul; 57(7):999-1004. PubMed ID: 18555843
[TBL] [Abstract][Full Text] [Related]
14. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
18. Endocrine characteristics of polycystic ovary syndrome (PCOS).
Szilágyi A; Szabó I
Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
[TBL] [Abstract][Full Text] [Related]
19. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome.
Tan TT; Lui SK; Satgunasingam N; Khalid BA
Med J Malaysia; 1989 Dec; 44(4):302-6. PubMed ID: 2520038
[TBL] [Abstract][Full Text] [Related]
20. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]